Innovations in Combating Infectious Diseases: Opportunities in therapeutics and diagnostics through application of proteomics, genomics, nanotechnology, and novel sources of lead generation Infectious disease is not merely a problem of the past; despite significant breakthroughs achieved during the last century in the development of antibiotic, antiviral, and antipara Market: Biotechnology , Diagnostics / Medical technology , General Pharmaceuticals / Health
|
2010 |
3.835,00$ |
Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players Injectable bio-implants provide rapid non-surgical treatments and offer effective replacement, restoration, or modulation of function to lost, damaged, or dysregulated physiology. Market: Biotechnology , Health Care & Medical Products , General Pharmaceuticals / Health
|
2010 |
3.835,00$ |
Global Pharmaceuticals, Biotechnology & Life Sciences Datamonitor's Global Pharmaceuticals, Biotechnology & Life Sciences industry profile is an essential resource for top-level data and analysis covering the Pharmaceuticals, Biotechn Market: Biotechnology , Pharmaceuticals / Medicines , General Pharmaceuticals / Health
|
2010 |
250,00$ |
Biotech for Wellness: Driving successful R&D and licensing in nutraceuticals through new business models and collaboration Over the past 5 years all of the major food and beverage companies have undergone a fundamental strategy shift to take into account the increasing consumer focus on health and well Market: Biotechnology
|
2010 |
4.795,00$ |
Future of Red Biotechnology in China Red biotechnology (RB) refers to the biotechnology applied in pharmaceutical production and it has become the most important part in biotechnology industry. About 60% of achievemen Market: Biotechnology
|
2010 |
10.000,00$ |
Biomarkers in Late Stage Clinical Trials: Applications, opportunities and activities of leading players Understand and evaluate the growth potential of emerging technologies.
/ Understand biomarker activity in clinical trials of leading market players.
/ Gain knowledge about the relative importance of the biomarker late stage clinical trials technologies in the next five years for investment opport Market: Biotechnology
|
2010 |
3.835,00$ |
Building Biotech Technology Transfer Opportunities: Sponsor and developer strategies for success Drug developers have long been under pressure to introduce new products in an environment of escalating R&D costs, blockbuster patent expiration and resulting generic competition. Market: Biotechnology
|
2010 |
3.835,00$ |
Nanotechnology in Healthcare: Market outlook for applications, tools and materials, and 40 company profiles The advent of healthcare nanotechnology has had a vast impact in the fields of drug delivery and diagnostics. The role of nanotechnology in healthcare is very important in terms of Market: Biotechnology , Diagnostics / Medical technology
|
2010 |
3.835,00$ |
Global Top 10 Biotechnology Companies Industry, Financial and SWOT Analysis Performance of the global biotechnology market on the basis of sales, volume and respective growth patterns over the past five yearsObtain descriptive profiles of the top ten leading players including strategic initiatives undertaken in the l Market: Biotechnology
|
2009 |
1.895,00$ |
Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative technologies, growth opportunities and the future market outlook Microarrays and biochips are small devices capable of detecting and measuring large numbers of biomarkers simultaneously. Although microarrays have been in research use for over a Market: Diagnostics / Medical technology , Biotechnology
|
2009 |
3.835,00$ |
Advances in the Stem Cell Industry: The future impact of innovation, and an evaluation of the commercial landscape An important milestone in the development of stem cell technology occurred in 2007, when researchers induced human cells into a stem cell state using defined genetic factors. These Market: Biotechnology , Diagnostics / Medical technology
|
2009 |
3.835,00$ |
The Global Bioinformatics Market: Market size, forecasts and company profiles The integration of biology and informatics has been very integral part of the life science applications. Changing trends in the drug discovery procedures such as strict regulations Market: Pharmaceuticals / Health , Biotechnology , General Pharmaceuticals / Health
|
2009 |
3.835,00$ |
Biotechnology: Global Industry Guide Datamonitor's Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market Market: Biotechnology
|
2009 |
1.495,00$ |
Molecular Diagnostics in Cancer Testing Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umb Market: Biotechnology
|
2009 |
3.400,00$ |
Future of Green Biotechnology in China This report is the unique and latest one available in the world to provide good understanding about Green Biotechnology (GB) in China and to find out business opportunities in this Market: Biotechnology
|
2009 |
6.500,00$ |
The Future of White Biotechnology in China The future of white Biotechnology is attractive in China, and considerable progress in white biotechnology has been made in recent years. China’s production of many vitamins and po Market: Biotechnology
|
2009 |
12.000,00$ |
Cell-Based Assays for Drug Discovery The area of drug discovery tools is one of the newest and most important sectors of pharmaceutical research and development. The term drug discovery tools usually refers to high-co Market: Biotechnology
|
2009 |
3.400,00$ |
Companion Biomarkers in Drug Development The term "companion biomarker" means that a particular diagnostic test is specifically linked to a therapeutic drug either in drug development or in the clinic. Biomarkers of disea Market: Biotechnology
|
2009 |
3.400,00$ |
Evolving Trends in Biopharmaceutical Licensing: Deal assessments, drivers and resistors How will the increasing competition for attractive Biopharma licensing candidates affect deal terms and values?
/ How can Biopharma companies improve their licensing strategies to ensure future growth?
/ What have been the major trends in licensing agreements between Biopharma and Pharma over 2001 Market: Biotechnology
|
2009 |
3.835,00$ |
RNA Interference Markets Since its discovery, the naturally occurring RNA (ribonucleic acid) interference effect has been acclaimed as the most exciting technical breakthrough in biological research in the Market: Biotechnology
|
2008 |
3.400,00$ |
Biometrics for Defence 2008 Biometrics refers to automated identification methods using unique human identifiers such as fingerprints and iris and facial patterns. Biometrics, regarded as a sophisticated mean Market: Biotechnology , Other / Inter-Branch
|
2008 |
1.927,00$ |
Biotechnology in Asia-Pacific Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s recent performance and future prospects / / Incorporates in-depth five forces competitive environment analysis and scorecards / / Includes a five-year forecast of the in Market: Biotechnology
|
2008 |
250,00$ |
Biotechnology in Belgium Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s recent performance and future prospects / / Incorporates in-depth five forces competitive environment analysis and scorecards / / Includes a five-year forecast of the in Market: Biotechnology
|
2008 |
250,00$ |
Biotechnology in Canada Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s recent performance and future prospects / / Incorporates in-depth five forces competitive environment analysis and scorecards / / Includes a five-year forecast of the in Market: Biotechnology
|
2008 |
250,00$ |
Biotechnology in China Contains an executive summary and data on value, volume and/or segmentation / / Provides textual analysis of the industry’s recent performance and future prospects / / Incorporates in-depth five forces competitive environment analysis and scorecards / / Includes a five-year forecast of the in Market: Biotechnology
|
2008 |
250,00$ |